- Home
- AMBO vs BCLI Comparison
AMBO vs BCLI Comparison
Compare AMBO & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBO
- BCLI
- Stock Information
- Founded
- AMBO 2000
- BCLI 2000
- Country
- AMBO United States
- BCLI United States
- Employees
- AMBO N/A
- BCLI N/A
- Industry
- AMBO Other Consumer Services
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMBO Real Estate
- BCLI Health Care
- Exchange
- AMBO Nasdaq
- BCLI Nasdaq
- Market Cap
- AMBO 8.8M
- BCLI 7.9M
- IPO Year
- AMBO 2010
- BCLI N/A
- Fundamental
- Price
- AMBO $3.19
- BCLI $1.16
- Analyst Decision
- AMBO
- BCLI Strong Buy
- Analyst Count
- AMBO 0
- BCLI 1
- Target Price
- AMBO N/A
- BCLI $30.00
- AVG Volume (30 Days)
- AMBO 27.3K
- BCLI 141.4K
- Earning Date
- AMBO 12-30-2024
- BCLI 05-15-2025
- Dividend Yield
- AMBO N/A
- BCLI N/A
- EPS Growth
- AMBO N/A
- BCLI N/A
- EPS
- AMBO 0.11
- BCLI N/A
- Revenue
- AMBO $9,392,000.00
- BCLI N/A
- Revenue This Year
- AMBO N/A
- BCLI N/A
- Revenue Next Year
- AMBO N/A
- BCLI N/A
- P/E Ratio
- AMBO $28.89
- BCLI N/A
- Revenue Growth
- AMBO 2.50
- BCLI N/A
- 52 Week Low
- AMBO $1.00
- BCLI $0.72
- 52 Week High
- AMBO $5.55
- BCLI $10.05
- Technical
- Relative Strength Index (RSI)
- AMBO 59.88
- BCLI 50.13
- Support Level
- AMBO $3.02
- BCLI $1.12
- Resistance Level
- AMBO $3.39
- BCLI $1.26
- Average True Range (ATR)
- AMBO 0.32
- BCLI 0.14
- MACD
- AMBO 0.01
- BCLI 0.02
- Stochastic Oscillator
- AMBO 64.37
- BCLI 42.86
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.